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Recent knowledge of immunity in central nervous system virus infections 
indicates a  need for a  restudy of rabies.  Questions are now raised as to 
whether non-virulent vaccines are capable of inducing an active immunity 
against subsequent test exposure and whether vaccines administered after 
exposure are capable of controlling the infection.  Moreover, with respect 
to rabies, statistics fail to show superiority of "live" over "killed" vaccines, 
nor indeed any advantage gained for the most part in commencing vaccine 
treatment within 14 days after bite (1).  Finally, published experiments on 
the  immunizing potency of antirabies  vaccines  contain meagre  evidence 
that vaccines will immunize against rabies and this evidence is for the most 
part inconsistent, non-quantitative, and fails  to  indicate a  superiority of 
one vaccine over another (2). 
The need for a quantitative practical test for determining the immunizing 
potency of rabies vaccines seemed to be met by our finding that  inbred 
W-Swiss  mice were  highly susceptible and  uniform in  their  response  to 
rabies virus  (3).  With these mice methods have been developed for the 
testing of vaccines and reports made of the results of these tests (4).  In 
the present paper these procedures and results are described in more detail. 
W-Swiss Mice as Animals of Choice for Testing Antirabies  Vaccines 
The W-Swiss mice, selectively bred in our laboratory for susceptibility 
to central nervous system (C.N.S.) virus infections, have proved especially 
satisfactory for testing antirabies vaccines for the following reasons. 
These Mice Are Highly Susceptible  and Relatively  Uniform in  Their Re- 
sponse to Rabies  Virus.--Virus-containing  brain tissue diluted 1 to 100 with 
10 per cent horse serum plus distilled water and injected intracerebrally in 
0.03 cc. amounts into 3 weeks old Swiss mice is passed on serially from the 
brains of the injected mice when they become prostrate.  Such virus from 
prostrate mice gives reliable titration results in repeated tests, as illustrated 
in  Table  I. 
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It will be noted that with increasing dilutions of virus,  50 per cent or 
more of tested mice succumb regularly until a  critical point is reached be- 
yond which less than 50 per cent succumb.  This dilution is regarded as 
the titration end point and as containing 1 minimum lethal dose (M.L.D.) 
of virus.  Duration of life varies little from an average which depends on 
the amount of virus administered.  Other strains of mice and  species of 
animals have given less uniform results.  The susceptibility of the 3 weeks 
old Swiss mouse is high, as shown in Table I, 0.03  cc. of the 10  -6 or 10  -7 
dilution proving fatal to  the majority of individuals tested.  This  sensi- 
tivity is at least  10 times that of guinea pigs or rabbits injected similarly 
per  gram  of  body  weight.  Certain  other  strains  of  mice  have  proved 
equally susceptible  (5)  but not equally uniform in  their response  to  the 
virus. 
TABLE  I 
Intracerebral Tilrations  of Early Passage Dog 15811 Virus in 3 Weeks Old W-Swiss Mice 
Test 
1 
2 
3 
4 
5 
Pas- 
sag 
10-4 
8  *7, 8, 8 
17  8, 8 
22  8, 8, 9 
24 
24  7, 9 
Fate of mice given 0.03 cc, mouse-braln virus intracerebraUy in dilutions 
Titre 
lO-S  lOS  lO~ 
8, 8, 11 
9,  11 
10, 10, 11 
9, 10, 10, 11 
9, 14,  15 
12, 14 
9,  12, 14 
8,  10, 10 
9, 9, 11, 12 
S, S 
15, 15, S 
10, S, S, 
11, 11, 12, 12 
lO-S 
13, S, S 
14, S, S, S 
0.03 cc. 10~+ 
0.03  "  10  -~ 
0.03  "  10  -7 
0.03  "  10  -7 
0.03  "  10-7 
* Day  of death from rabies following injection. 
S  =  mouse remained well.  --  --- dilution not tested. 
A  similarly  uniform  response  and  high  susceptibility  are  obtained  if 
mouse brain  passage  virus  is  titred  intramuscularly. 
Mouse passage virus is prepared in twofold dilutions and 0.01 cc. injected 
through a 0.3 cm., No. 26 needle pointed distally into the lower third of the 
gastrocnemius muscle.  At least four mice are injected with each dilution 
of virus.  A series of such titrations is illustrated in Table II.  The twofold 
dilutions used in  testing this  muscle route of infection give less uniform 
results than the tenfold dilutions employed in testing by the intracerebral 
route.  Nevertheless, 50 per cent or more mice succumb with fair regularity 
to increasing dilutions of virus, until a point is reached beyond which less 
than  50  per  cent  succumb.  Duration  of  life  increases  regularly  with 
increase in dilution of virus given.  The susceptibility of 3 weeks old Swiss 
mice to this route of infection is high, 0.01  cc. of virus diluted 1 to 320 to 
1  to  2,560  generally proving fatal.  Other  animal  species have thus far LESLIE  T.  WEBSTER  89 
proved so irregular in their response to peripheral injection of rabies virus 
that no quantitative peripheral test has been developed  (2). 
Certain  variables  which modify uniformity,  regularity,  and end points 
of titrations require careful control.  (a)  Strains of virus differ in virulence. 
(b)  Strains  of virus increase  in virulence  with mouse  brain passage.  (c) 
The age of the mouse modifies the virulence of the virus markedly.  These 
variables will be discussed in detail in a later report. 
These  mice  contract  the dassical type  of disease after injection of a  very 
small amount of virus, 0.01 cc. of a 1 to 320 dilution, into the gastrocnemius 
muscle.  If passage virus is injected, it first appears in the lumbar cord 3 
to 5 days later and passes quickly to the brain where it multiplies rapidly. 
The first  signs of disease  usually appear on  the  9th  to  14th days in the 
form of flaccid paralysis of the injected limb.  Convulsions and prostration 
TABLE  II 
Intramuscular Titrations of Early Passage  Dog 15811 Virus in 6 Weeks Old W-Swiss Mice 
Fate of mice given 0.01 cc. of mouse-brain virus intramuscularly in dilutions 
F4  1:80  1:160 
1  *11, 16, 21  13, 14, S, S 
32  13, 13,__19, S  _-" 
4 
5  --  11, 12, 14, S 
6  --  15, 15, 21, S 
7  --  113, 13, 14, 16 
8  10, 10, 16, 18110, 13, 13, 18 
1:320  1:640  1:1,280 
11, 14, S, S  --  -- 
12, 12, 16, S  --  15, 17, S, S 
13, 16, 22  26, S,S,S  13, S,S,S 
11, 13, S  18,16, S,S  S,S,S,S 
14,17,18, S  12, 17, S,S  11,16,17, S 
12,18,17, S  14,14,19,$12,14,14, S 
10, 13, 16, 21 18, 20, 25, S 11, 13, 20, S 
10, 13, 13, 15 13,18, S,S  13,13,16, S 
1:2,560 
,S, S, S, S 
S, S, S, S 
14, S, S, S 
12, 15, S, S 
13, S, S, S 
13, 13, S, S 
Titre 
1:5,120 
--  0.01 cc. 1:320+ 
--  0.01  "  1:1,280-~ 
--  0.01  "  1:640 
--  0.01  "  1:640 
15,  S, S, S  0.01  "  1:2,560 
S, S, S, S  0.01  "  1:2,860 
--  0.01  "  1:1,280 
--  0.01  "  1:2,500+ 
* Day of death from rabies following injection. 
S  =  mouse remained well.  --  =  dilution not tested. 
follow after 24 hours, terminated  usually  by death in a varying period of 
time.  An  occasional  mouse  survives.  At  autopsy  lesions  are  generally 
limited  to  the  posterior  root  ganglia,  spinal cord,  and  brain  and  consist 
of the characteristic perivascular cuffs of round cells plus an occasional focus 
of similar cells near a necrotic nerve cell.  A  few nerve  cells in Ammon's 
horn, posterior  ganglia,  and  cord  are  usually affected.  If street  virus is 
injected,  the incubation period and duration of disease are  longer.  Some 
of the animals become vicious before paralysis sets in.  At autopsy Negri 
bodies are found in the cells of the lumbar cord but most frequently in the 
region of Ammon's horn. 
The response  of 5  weeks old mice to 12th passage virus from dog 15811 
is  shown in  Table  III.  Depending  upon the  amount  of  virus  injected, 
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and prostration 2 to 40 days later.  One paralyzed mouse recovered and 
remained well 3 months. 
The  W-Swiss mice  are readily immunizable  against measurable doses of 
virus given intracerebraUy or intramuscularly.  10,000 intracerebral lethal 
TABLE  III 
Response of 5 Weeks Old Mice to 0.01 Cc. Rabies Virus,  Dog 15811, Twelfth Passage, 
Injected into the Gastrocnemius Muscle 
Response  of mice on days following injection  DUu-  ~  . 
tion 
in-  --  ~  17  19  20  jected  8  9110  11  12  13  14  15  16  18  21  22[ 23  24  25  30  35  40  45  50  55  60 
1:40  1  Pa D  I 
2  PaPrD 
3  Pa D 
4  Pa  ~  D 
5  Pa Pa  Pa Pa D 
6  Pa  Pa Pa Pz D 
7  Pa Pa Pa  Pa Pa Pe 
8 
1:80  1  Pa D 
2  Pa D 
3 
4  ! 
5 
6 
7 
8 
1:150 
1:320 
Pa PaPaPa  Pa Pa'Pa  Pa  Pa  Pa  Pa  D 
Pa Pz,D 
Ps  Pa Pa Pa  Pa PaPs  Pr PrD 
Pa  Pa Pa Ps,Pa Pa Pe  Pa Pa Pa  !Pa Pa Pa Imp Imp Iml:  Imp Imp Imp Im~ 
1  Pa~P:  PrD 
2  Pa D 
3  PeiPr D 
4  Ps  Pr Pr PxD 
5  ,Pa Pr P:  PrD 
6  Pa PaPs  Pa Pr PI  PrD  i 
7  Pe  Pa Pa Ps  Pa PaPaIPaD 
8 
9 
I0 
1  Pa D 
2 
3 
4 
5 
6 
7 
8 
9 
10  ! 
Pr Pr D 
Pa Pa PzlPr PrD 
PaPaPs  Pr Pr P~D 
Pa  Pa Pa Pe  Pr Pr I) 
Pa Pa Pe  Pa Pa 1)e  D 
Pa =  paralyzed.  Pr -- prostrate.  D  =  dead.  Imp =  improved. 
doses  or more  of  virus injected  intraperitoneaUy  in  a  single  dose  will  im- 
munize  these  mice  against  a  subsequent  intracerebral  injection  of  10  to 
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Table IV shows the results of such a test.  Batches of 30 day old mice 
received an intraperitoneal injection of 0.5 cc. of 175th passage mouse brain 
virus from dog R-1 in dilutions of 1: 100, l: 1,000, 1: 10,000, and 1:100,000 
respectively.  A virulence titration run at the same time indicated that the 
vaccinated mice had received  160,000,  16,000,  1,600, and 160 lethal doses 
respectively.  3 weeks later their immunity was tested by injecting them 
intracerebrally with the same strain of virus in dilutions of 1:1,000 through 
1:10,000,000.  The controls succumbed through the  1:I,000,000  dilution, 
while the mice vaccinated with 160,000 doses survived 1,000 intracerebral 
lethal doses; the mice vaccinated with 16,000 doses survived 10 to 100 lethal 
doses, those vaccinated with 1,600 doses possibly would have survived one 
lethal dose, and finally those vaccinated with 160 doses were not immunized. 
TABLE  IV 
Immunity of Mice Following Vaccination  with Virulent 175th Passage Dog Virus R-1 
Vaccine given 
None 
0.5 cc. 1:100 
0.5  "  1:1,000 
0.5  "  1:10,000 
0.5  "  1:100,000 
None  I 
160,000  / 
16,000~ 
1,600 
Fate of mice given 0.03 cc. of test virus intracerebrally in dilutions 
10-'2 
S, S 
7, S, S 
7, 13, 21 
101 
S, S, S 
13, S, S, S 
7, 7, S, S 
12, 12, 13 
10-4  10-5  lO-e  10-7 
Amount 
of im- 
munity 
in 
intra- 
cerebral 
lethal 
doses 
--  "7, 9, s  ~, 11,12,12, 13:s, s, s, s, s 
13, s, s  s, s, s, s  --  --  1,000 
13, S, S, S  20, S, S, S  --  --  I0-100 
7, S, S, S  8, 9, S, S  --  --  1+ 
11, 12, 13, 21  11o 13, 17, 21  --  --  0 
* Day  of death from rabies following injection. 
S  =  mouse remained well.  --  --  dilution not tested. 
It will be noted besides that the vaccinated mice, unlike the non-vaccinated 
controls,  occasionally  showed individual irregularities  in response. 
This active immunity is influenced by a number of factors which must 
be  carefully  controlled.  (a)  Different  strains  of virus differ in  their im- 
munizing capacity.  (b)  Different strains of virus differ in their tendency 
to induce rabies following intraperitoneal injection.  (c)  The susceptibility 
of the mice  to intraperitoneal injection and their subsequent capacity  to 
be immunized are  markedly  affected by age.  These factors will be  con- 
sidered in detail in a forthcoming paper. 
For the purpose of this paper it is sufficient to note that under the condi- 
tions described above, immunity can be demonstrated in 7 days and for at 
least 9 months.  Virus given subcutaneously as a vaccine is more active in 
inducing rabies  and less effective  in immunizing the  mice.  Neutralizing 
antibodies in the serum appear in the intraperitoneaUy vaccinated mice at 92  IMMUNIZING  POTENCY  OF  ANTIRABIES  VACCINES 
the  same  time  as  does  immunity.  In  subcutaneously  vaccinated  mice, 
they  usually  are  not  demonstrable. 
W-Swiss  mice  fail  to  react  to  vaccination  commenced  subsequent  to  a 
test exposure to the virus.  Despite the use of a peripheral route of inocula- 
tion with a  minimum infecting dose of virus, a  method of inoculation  that 
is followed by long incubation periods and a  mortality rate of less than I00 
per  cent  (Table  III), vaccines  of all  sorts  have proved ineffective in  our 
hands in altering the mortality rates or the  course of infection from those 
in  unvaccinated  mice. 
Development of Swiss Mouse Immunity Test 
Having learned that W-Swiss mice are highly susceptible and uniform in 
response  to  rabies  virus and  that  they  can be readily immunized against 
subsequent,  though  not prior test exposure to  the  virus, we  set about de- 
veloping a  simple quantitative  test for measuring the immunizing potency 
of  a  given  vaccine  against  subsequent  measured  doses  of  virulent  virus. 
The first problem had to do with standardizing the size and number of doses of vaccine 
for injection into  the  mice: Since  most of the  commercial vaccines in  this  country, 
whether designed for the treatment of man or prophylaxis of animals, have been rendered 
non-virulent through treatment with phenol or chloroform, they received first considera- 
tion.  Undiluted  vaccine  was  poorly  tolerated  by  the  mice,  whether  given  intra- 
peritoneally as a vaccine or intracerebrally as a test for virulence.  Apparently this poor 
tolerance  was  due  to  the  inactivating  agent.  Consequently,  each  preparation  was 
diluted 1 to 10, regardless of the concentration of brain emulsion or of inactivating agent. 
This dilution of vaccine proved entirely harmless.  The dose of vaccine prescribed for 
man or dogs obviously could not be employed for mice.  ~th of  the prescribed dose, 
however, was readily tolerated by the mice.  Hence a standard practice was adopted of 
diluting each vaccine 1 to 10 and injecting ~th of the stated volume, making a total 
dilution of 1:80.  In the case of the vaccines for treatment of man put up in 2 cc. doses, 
cc. of a 1 to 10 dilution was given; when put up in ~  cc. doses, 0.06 cc.  In the case 
of the vaccines for animal prophylaxis put up in a single 5 cc. dose, 0.6 cc. was given. 
This diluted dose for a  15 gin. mouse is still approximately 5 times that prescribed for a 
10 kilo child or animal per gram of body weight and is therefore regarded as an ample 
amount for testing. 
The intraperitoneal route of injecting the vaccine was chosen on the basis of tests 
with virulent virus mentioned above.  The difference in effectiveness of inactive vaccines 
given by intraperitoneal and subcutaneous routes is shown later in Experiment 1.  A 
single injection was given if a canine vaccine was being tested.  In the case of vaccines 
for man, six daily doses proved somewhat less effective in mice than fourteen, but three 
usually sufficed to demonstrate whether the vaccine was antigenic.  The difference in 
effectiveness of a different number of doses is also illustrated in Experiment 1 described 
below.  The time of testing immunity was chosen  at 3 weeks  after the first dose of 
vaccine.  At this point experience showed immunity to be at a maximum.  The test 
dose was given intracerebraUy in the early tests in dilutions containing 1, 10, 100, and LESLIE  T.  WEBSTER  93 
1,000 ~.L.D., as shown in Table I.  Later, when a study of canine vaccines was made to 
demonstrate the presence of even a  minute amount of immunizing potency, the more 
sensitive gastrocnemius muscle route was employed in 2, 4, 8, 16, and 32 M.LD. doses, 
as shown in Table II.  The tested animals, including unvaccinated controls which were 
of the same age as the vaccinated animals and which were  set apart at the outset of the 
experiment, were observed for 60 days for signs of rabies and then discarded. 
To determine whether or not a vaccine as marketed contained virulent virus, it was 
diluted 1 to 10 and injected intracerebraUy in 0.03 cc. amounts into at least five 2 weeks 
old Swiss mice. 
Briefly, the mouse test  for measuring the immunizing potency of any 
antirabies vaccine is carried out as follows:  (a)  Dilute the vaccine tenfold. 
(b)  Segregate sixteen 3  weeks old Swiss mice for vaccination and sixteen 
of the same age as controls.  Provide at least  five additional 2 weeks old 
mice for the virulence test.  (c)  Inject the 2 weeks old mice intracerebrally 
with 0.03  cc. of the diluted vaccine to determine the presence of virulent 
virus.  (d)  If the vaccine is designed for the treatment of man, inject six- 
teen mice with  1/~th the stated dose  of diluted  vaccine  intraperitoneally 
daily for 3  or 6  days.  If the vaccine is  for canine prophylaxis, inject a 
single dose of ~/~th the stated amount.  (e)  3  weeks after the  first injec- 
tion, test vaccinated mice plus controls with 2, 4, 8, and 16 intramuscular 
lethal doses of virulent virus respectively (or 1,  10, and  100 intracerebral 
lethal doses). 
Details for maintaining titre of the test virus plus additional precautions 
necessary for consistent results are given above. 
Results of Mouse Tests on Commercial Vaccines 
Virulent Vaccines for Treatment of Man.--A few vaccines prepared accord- 
ing to the dilution methods of HSgyes or Harris were tested with positive 
results.  Upon intracerebral injection they invariably proved virulent but 
no attempt was made to titrate the amount of virulent virus in the various 
samples.  Injected intraperitoneaUy as  a  vaccine,  they proved  harmless 
yet immunized the mice within 10 days to 100 intracerebral lethal doses of 
test  virus.  The  immunity persisted  at  least  9  months. 
Non-Virulent  Vaccines for  Treatment  of Man.--Tblrty-two  phenolized 
(Scruple)  and  one  chloroformized (Kelser) vaccine for treatment of man 
obtained from nine different manufacturers have been tested with results 
shown in Table V.  All proved non-virulent.  The phenolized products of 
seven  manufacturers have not  immunized mice  consistently  to  any  sig- 
nificant degree, according to tests on two to four different lots of each.  The 
phenolized vaccine from another manufacturer (No.  II), however, has in- 
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of twelve separate  preparations.  Finally, a  chloroformized vaccine from 
firm  No.  I  also  immunized  mice  readily. 
The active phenolized product from firm No. II has been studied in detail 
with  results  illustrated  in  the  following protocol. 
Experiment 1.--No. II vaccine, a 4 per cent phenolized preparation put up in 14 doses 
of 2 cc. each, was tested for virulence by diluting it 1 to 10 and injecting 0.03 cc. intra- 
cerebrally into 10 mice.  It was then given as a vaccine to batches of 75 mice in the 
following manner.  Group A received 1 dose of 0.25 cc. of vaccine diluted 1 to 10 intra- 
peritoneally.  Group B received the same dose intraperitoneally for 6 days; group C the 
same dose intraperitoneally every other day for 6 days; group D  1 dose daily intra- 
TABLE V 
Results of Mouse Potency Tests of Commercial Non-Virulent  Vaccines Designed  for 
Human Treatment 
Manufacturer's number 
I 
II 
III 
IV 
V 
VI 
VH 
VIII 
IX: 
total:  9 
Type  of vaccine 
Chloroformized 
Phenolized 
It 
it 
tl 
tt 
tt 
¢i 
Number 
of 
pre.para- 
tlons 
tested 
1 
12 
4 
2 
3 
3 
3 
3 
2 
33 
Amount of immunity in lethal  doses 
10 
O, 1, 10, 10, 10, I0, 10, 10, 100, 10, 100, 10 
1, O, O, 0 
O, 0 
O, O, 0 
O, 1, 0 
1, 1, 0 
1, 1, 1 
0, 0 
Samples positive from 2 of 9 companies 
peritoneally for 14 days.  Group E  received the fourteen daily doses subcutaneously, 
and group F received no vaccine.  The vaccinated mice were then tested for immunity 
and for the presence of serum-neutralizing antibodies, 8, 16, 28, 78, 136, and 387 days 
after the first injection of vaccine. 
The results of this experiment are summarized in Tables VI and VII  and 
Text-figs.  1  and  2.  The  vaccine proved, first  of all,  to  be  non-virulent 
according to the intracerebral test.  It immunized in 8 days mice of groups 
B, C, and D, which had received multiple doses of vaccine intraperitoneally, 
against 10 to 100 test intracerebral lethal doses of virus.  At 16 and 28 days 
the results were approximately the same and at 78 and  136 days these in- 
traperitoneally vaccinated groups still showed immunity; but at 387 days, 
when  next  tested,  they were  no longer immune.  A  single  dose  given  to LESLIE  T.  WEBSTER 
TABLE  VI 
Immunity  of  Mice  Following  Vaccination  with  No.  II  Phenolized  Vaccine 
95 
t~ 
A 
B 
C 
D 
E 
F 
A 
B 
C 
D 
E 
F 
A 
B 
C 
D 
E 
F 
A 
B 
C 
D 
E 
F 
Type of vaccination 
Fate of vaccinated mice given 0.03 cc. of test virus 
"~ ~  intracexebrally in dilutions 
P~ 
o'0 
~  lO-a  10-4  10-6 
,  I 
i.p., 1 dose  --  *10,  10, 12 
"  6 doses (1 per day)  13, S, S 
"  6 doses  (1 every other day)t  S, S, S 
"  14 doses  (1 per day)  13,  S, S 
s.c., 14 doses (1 per day)  8, 11, 12 
No vaccination  --  8, 8, 8 
i.p., 1 dose  --  12, 12, 12 
"  6 doses (1 per day)  --  14, 14,  S 
"  6 doses (i every other day)  28, S, S 
"  14 doses (I per day)  --  S, S, S 
s.c., 14 doses (1 per day)  --  9, 9, II 
No vaccination  --  8, 10, 10 
i.p., 1 dose  --  9, 9, 9 
"  6doses  (lperday)  11,21, S  16,  S,S 
"  6 doses (I every other day)  14, 15, S  20, S, S 
"  14 doses (1 per day)  S, S, S  S, S, S 
s.c., 14 doses (1 per day)  --  8, 9, 10 
No vaccination  --  8, 9, 9 
i.p., 1 dose  --  I 8, 8, 11, 17 
"  6 doses  (1 per day)  --  10, S, S, S 
"  6 doses (1 every other day)  --  13, S, S, S 
"  14 doses (l per day)  --  13, 13, S, S 
s.c., 14 doses (1 per day)  --  10, 10, 10, 10 
No vaccination  I0, 10, 10, 10 
i.p., 1 dose  --  ! 8, 9, 9, 12 
"  6 doses (1 per day)  --  10, 10, 14, S 
"  6 doses (1 every other day)  9, S, S, S 
"  14 doses (1 per day)  ~  S, S, S, S 
s.c., 14 doses (1 per day)  --  10, 10, 11, 13 
No vaccination  --  8, 9, 12, 12 
i.p.,  1  dose  --  8, 8, 8, 8 
"  6 doses (1 per day)  9, 10, 11, 11 
"  6 doses (1 every other day)  --  9, 10 
"  14 doses (1 per day)  --  8, 8, 9, 10 
s.c., 14 doses (1 per day)  8, 9, 10, 11 
No vaccination  6, 7, 8 
12, 13, S 
S, S, S 
11,  15, S 
S, S, S 
12, 12, 13 
9, 12, 12 
12, 12, 12 
S, S, S 
20, S, S 
S, S, S 
11, 11, S 
10, 12, 12 
12, 12, S 
S, S, S 
S, S, S 
S, S, S 
10, 11, 11 
12, 14, 14 
10, 11, 17, S 
13, S, S, S 
S, S, S, S 
S, S, S, S 
10, 11, 12, S 
9, 10, 10, 16 
12, 13, 13,  13 
13, S, S, S 
18, 21, S, S 
15, S, S, S 
12, 13,  S, S 
12, 13, 13, 14 
8, 9, 10, 10 
12, 13, 17, S 
9, 12 
9, 9, 9, 11 
9, 9, 9, 10 
9, 9, 10 
S, S, S  I 
S, S, S  100 
S, S, S  I-I0 
S, S, S  I00 
13, S, S  1 
II, II, S 
II,  15, S  0 
IS, S, S  I0 
S, S, S  10-100 
S, S, S  I00 
12, S, S  I 
12, 20, S 
14, 16, S  0 
--  10+ 
--  10+ 
--  100+ 
11, S, S  0 
14, S,  S 
11,  S, S, S  0 
S, S, S, S  I 
S, S, S, S  10 
13, S, S, S  1 
S, S, S, S  0 
S, S, S, S 
--  <10 
--  10 
--  10 
--  100+ 
--  <10 
12, 12,  S, S 
10, 11, 16, S  0 
--  0 
--  0 
--  0 
12, 13  0 
--  0 
Day  of death  of mouse  following  injection. 
t  Only  four  of total  six injections  received  at  time  of 8  day  test. 
S  --- mouse  remained  well 30 days.  --  =  dilution  not  tested. 
group A intraperitoneaUy and 14 doses to group E subcutaneously failed to 
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The results of tests for resistance were paralleled by those for neutralizing 
antibodies except that group A mice, which had received the single intra- 
peritoneal dose  and  showed no immunity on  inoculation, did  show  cir- 
culating antibodies in every case. 
Many preparations of this particular phenolized vaccine (No. II) have 
been tested.  At no time has it been found to contain virulent virus and 
TABLE  VII 
Neutralizing Antibodies in Sera of Mice Vaccinated with No. II Phenoli~.ed Vaccine 
Source of sera 
~  Type of vaccination 
i.p., 1 dose 
"  6 doses (1 per day) 
"  6 doses (1 every other day)t 
"  14 doses (1 per day) 
s.c.,  14 doses (I per day) 
No vaccination 
i.p., 1 dose 
"  6 doses (l per day) 
"  6 doses (I every other day) 
"  14 doses (I per day) 
s.c.,  14 doses (I per day) 
No vaccination 
i.p., 1 dose 
"  6 doses (1 per day) 
"  6 doses (1 every other day) 
"  14 doses (1 per day) 
s.c., 14 doses (1 per day) 
No vaccination 
i.p., 1 dose 
"  6 doses (1 per day) 
"  6 doses (1 every other day) 
"  14 doses (1 per day) 
s.c.,  14 doses (1 per day) 
No vaccination 
~.JO  m~ 
days 
8 
"  I 
15 
~L 
28 
L, 
136 
t~ 
tL 
,t 
Fate of mice given 0.03 cc. of serum plus virus  6 
in dilutions  /~.~ 
•  d.o,  ~-; 
10-a  10-t  10-6  10-0  ~ u ~ .~ 
m 
m 
11, 12, 12, ', 
S, S, S, S 
12, S, S, S 
S, S, S, S 
9, 9, 9, 9 
I 
S, S, S, S 
S, S, S, S 
12, S, S, S 
S, S, S, S 
S, S, S, S 
*8, 9, 10, 10 
8, 8, 8, 10 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
9, 10, 10, 11 
9, I0, I0, I0 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
9, 10, 10p 10 
9, 9, 11, 11 
9, 10, 11, 12 
S, S, S, S 
S, S, S, S 
13, 14, S, S 
8, 8, 8, 9 
9, 9, 9, 10 
S,S,S,S 
S,S,S,S 
S,S,S,S 
S,S,S,S 
I0, I0,12, 
10, II, II, 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
I0, II, 12, 
11, 12, 13, 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
I0, 12, 13, 
10, 11, 13, 
11,11,11, 
S, SiS, S 
S,S,S,S 
S,S,S,S 
10, 10, 11, 
11, 11, 13, 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
12  13, S,S,S 
14  14, 14, 15, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
S, S, S, S 
12  12, 13, S, S 
13  13, 13, S, S 
13  13, S,S,S 
13  13, S, S  S 
13 
11  12, 13, 13, 13 
13  11, 15, S, S 
* Day of death of mouse following injection. 
t  Only four of total six injections received at time of 8  day test. 
S  =  mouse remained weU 30 days.  --  -  dilution not tested. 
100 
~t 
1 
100-1- 
L~ 
0 
10 
100+ 
6~ 
IS 
0 
0 
1,000 
100 
0 
yet it has never failed on test to induce neutralizing antibodies in human 
beings or in experimental animals and has rarely failed to render experi- 
mental animals immune.  The immunity corresponds to that produced with 
virulent virus.  It appears on or about the 8th day and endures approxi- 
mately  a  year.  Six  doses  give  somewhat less  immunity than  the  full LESLIE  T.  WEBSTER  97 
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TEXT-FIG. 2.  Neutralizing antibodies in blood serum of mice following injection with 
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fourteen  doses.  The  material  must  be given  intraperitoneally,  not  sub- 
cutaneously,  for  an  appreciable  or  consistent  effect.  Antibodies  appear 
following  a  single  intraperitoneal  injection,  although  this  amount  is  in- 
sufficient to render the animal immune to an intracerebral test dose.  The 
minimum  quantity required for immunization  of mice  is  at  least  5  times 
that prescribed for human beings per gram of body weight. 
The vaccines described above which failed to immunize  mice against  a 
subsequent  intracerebral  test  inoculation  likewise  failed  or  showed  very 
little  tendency to immunize  against  the peripheral  test inoculation.  The 
two vaccines which successfully immunized against  the intracerebral  were 
likewise  effective  against  the  peripheral  inoculation.  The  following 
TABLE  VIII 
Immunizing  Potency of No. I  Chloroform Vaccine in Mice against a Subsequent 
Intramuscular Test Infection 
Mouse group 
I~on-vaccinated controls. 
Vaccinated ............. 
Fate of mice inoculated  intramuscularly  with virus in dilutions 
1:20  1:40 
*7, 8, 8, 13, 16  9, 9,10,10,13 
S,S, S, S, S  $, S, S, S,S 
1:80 
8, 9, 9, 9, 13 
S, S, S, S, S 
I:160  .  1:320 
9,10, I0, S,S  9, II, S,S,S 
S,S,S,S, S  S,S,S,S,S 
Amount 
of im- 
m~ity 
In 111- 
tramu~- 
¢ul~ 
lethal 
doses 
8+ 
* Day of death of mouse following test injection. 
S  -  remained well 30 days. 
protocol illustrates  the immunity conferred by non-virulent  No. I  chloro- 
formized vaccine against a subsequent intramuscular injection of virus. 
Experiment 2.--Twenty mice received 0.06 cc. of No. I chloroformized  vaccine, diluted 
1 riO, daily for 14 days.  Twenty-five similar mice were set aside as controls.  3 weeks 
later both groups were tested intramuscularly.  0.01 cc. of virus in dilutions of 1:20 
through 1 : 160 was given to each of five vaccinated mice respectively.  The same dilu- 
tions plus 1:320 were likewise  given to the non-vaccinated controls. 
The results in Table VIII show that 100 per cent of non-vaccinated mice 
succumbed to the test virus through  the  1:80 dilution,  60 per cent in the 
1:160,  and  20 per cent in  the  1:320  dilution.  The  end point,  therefore, 
is taken as 1:160.  All vaccinated mice were immune to the  1:160,  1:80, 
1:40,  and  1:20 dilutions  and hence  to at least eight intramuscular  lethal 
doses. 
The next experiment illustrates the effect of decreasing dosage of vaccine 
on the amount of immunity obtained. LESLIE  T.  WEBSTER  99 
Experiment &--Batches of sixteen 3 weeks old mice were vaccinated in the following 
manner.  Batch A received six daily intraperitoneal doses of 0.25 cc. and batch B 0.05 
cc. of No. II phenolized vaccine, diluted 1 to 10.  Batch C received six daily intraperi- 
toneal doses of 0.06 cc. and batch D 0.012 cc. of No. I chloroformized vaccine diluted l 
to 10.  Batch E  was reserved as controls.  To detect the presence of virulent virus, 
each diluted vaccine was injected intracerebrally in 2 weeks old mice.  3 weeks later the 
vaccinated and control mice were tested for immunity against the intramuscular injection 
of virus. 
The virulence test showed no evidence of virulent virus in the vaccines 
and  the  immunity tests  gave  results shown  in  Table IX.  No. II vaccine 
given in six 0.25  cc. doses, which is a  total amount equivalent to about 5 
TABLE  IX 
Immunizing  Effects on Mice  of Antirabies  Vaccines 
Pkenolized and Ckloroformized Vaccines  for Treatment of Man 
Mouse group 
A. Phenolized No. II 
0.25 cc. 
B. Phenolized No. II 
0.05 cc. 
C.  Chloroformize.d  No. I 
0.06 cc. 
D. Chloroformized  No. I 
0.012 cc. 
E. Controls 
Fate of mice inoculated intramuscularly with 0.01 co. 
of virus in dilutions 
1:80  1:160 
*10, S, S, S  S, S, S, S 
16, 21, S, S  11, 25, S, S 
S, S, S, S  S, S, S, S 
10, 15, S, S  24, S, S, S 
9, 10, 11, 16 
1:320 
S, 
9, 
S, 
S, 
S, S, S, S 
S, S, S, S 
S, S, S, S 
I1, S, S, S 
9, 12, 19, 22 
:64C 
3, ! 
S, '. 
Amount 
ofimmuo 
nlty in 
intra- 
muscu- 
lar lethal 
doses 
* Day of death from rabies following injection. 
S -- mouse remained well.  -- = dilution not tested. 
times that for a  10 kilo child per gram of body weight, protected the mice 
against  at  least  four  lethal  intramuscular  doses,  whereas  when  given  in 
~/~th  that amount,  which more  nearly  approximates  the  relative amount 
given to a  child,  the  result was  negative.  The same proved true for the 
chloroformized  No.  1  vaccine.  Apparently  the  minimum  total  dosage 
sufficient to induce immunity in mice is in the neighborhood of 5 times that 
regularly prescribed for human beings per gm. of body weight. 
Non-Virulent  Vaccines for  Canine  Prophylaxis.--According  to  United 
States  Government regulations, all vaccines for  animal antirabies prophy- 
laxis must be non-virulent.  The questions at issue in this study were there- 
fore  twofold:  First,  are  the  products  now  on  the  market  non-virulent 100  IMMUNIZING  POTENCY  OF  ANTIRABEES  VACCINES 
according to  the mouse test;  and  second, do they  immunize mice against 
at  least  two lethal doses  of  test  virus  given under  controlled and  yet as 
nearly  natural  conditions  as  possible? 
The following results have been obtained on tests of five or more lots of 
vaccine from each of ten  commercial firms,  50 preparations  in  all:- 
None has contained virulent virus.  None has immunized mice against a 
subsequent test intracerebral injection of one lethal dose.  When tested by 
the  intramuscular  method  (Table  X),  twenty-seven  phenolized  prepara- 
TABLE  X 
Results of Potency Tests (Intramuscular) of Canine Vaccines 
Type of  Number of preparations  Amount of immunity in 
.Manufacturer's  number  preparation  tested  lethal doses 
Total: 9 manufacturers 
Chlomformizcd 
Phenol~ed 
c~ 
Cc 
41 preparations 
8, 8, 2, 4, 4, 8, 8 
4, 16, 8 
4, O, 2, 2 
O, 4, 2, 2 
O, 2, O, 0 
0, 0, 0, 0 
O, 1, 0, 0 
O, 0, 2, 2 
0, 0, 0 
2, 4, O, 0 
10  of  10  chloroform- 
ized vaccines from 2 
manufacturers,  posi- 
tive;  3  of  4  chloro- 
formized  vaccines 
from 1, and 27 phenol- 
ized vaccines from 7 
manufacturers, nega- 
tive 
tions from seven manufacturers for the most part proved negative.  Chloro- 
formized vaccines, on the other hand, especially from manufacturers Nos.  1 
and 3, have given results which merit further study. 
The  following  protocols  illustrate  the  intramuscular  potency  test  for 
canine vaccines and the type of result obtained. 
Experiment 4.--Batches of sixteen 3 weeks old Swiss mice were given a single injection 
of commercial vaccine diluted 1 to 10 in the following manner.  Batch A received 0.6 cc. 
of No. 1, 20 per cent chloroformized vaccine intraperitoneally, and batch B 0.1 cc. of the 
same dilution.  Batch C received 0.6 ce. of No. 1,33½ per cent chloroformized vaccine 
intraperitoneally, and batch D  0.6 cc. of the 20 per cent preparation subcutaneously. LESLIE  T.  WEBSTER  101 
Batch E was given 0.6 cc. of No. 2 vaccine intraperitoneally, batch F 0.1 cc. of the same 
preparation, while batch G received 0.6 cc. subcutaneously.  Batch H  was reserved 
without vaccination as controls.  At the same time 0.03 cc. of each vaccine diluted 1 
to 10 was injected intracerebraUy into five mice. 
3 weeks later the vaccinated and control mice were tested against an intramuscular 
injection of a mouse brain passage strain, 0.01 cc. of virus in dilutions of 1  : 20 to 1  : 320 
being injected into the gastrocnemius muscle. 
The chloroformized vaccines proved non-virulent.  In the immunity test 
(Table XI)  all dilutions of virus  through  1:320  proved  fatal to  the non- 
vaccinated mice.  Since  no  further dilutions were  tested,  1:320  is  taken 
as the end point, although the titre may have been still higher.  The No. 
TABLE  XI 
Immunizing Effect of Canine Antirabies  Vaccine on Mice 
Comparison of Effects of Subcutaneous and Intraperitoneal Routes of Injecting  Vaccine 
Mouse group 
~. No. 1 chloroformized  20% 0.6 cc. 
"  "  "  0.1  " 
"  "  33~%  0.6  " 
P.  "  "  20% 0.6  " 
i.  No. 2  "  "  0.6  " 
"  "  "  0.1  " 
"  "  "  0.6  "  r 
[i No vaccine 
i.p. 
t~ 
~t 
s.c, 
i.p. 
S.C. 
Fate of mice inoculated intramuscularly with virus 
in dilutions 
1:20 
*8, 9, 21 
7, 8, 15, 29 
8, S 
8, 8,  12 
8, 8,  lS 
7, S, 8, 8 
7, 10,  15 
1:40 
9,  10  25,~ 
8, 8,1,,  S 
9, 9, 
7, 7,  ~, S 
S, 8, 
8, 9,  ,9 
8, 9, 
8, 8, 
1:80  1:100 
I0,  S, $, S  S, S, S 
8, 8, 10, S  S, S,  S 
8, 14, 16  S, S 
8,  12,  13, S  9,  10, S 
8, 9, 9, 13  .,  11,  13, S 
lt,  11,  18,  S  10,  13,  15 
8, 8,  13  9,  11o 14 
9,  15, 22  ), 10, 11, 15 
1:320 
m 
m 
D 
8, 10, 22, 23 
Amoun| 
of immu 
nity in 
intra- 
muscu- 
lar letha 
doses 
4 
2 
2 
0 
0 
0 
0 
*  Day  of death  from  rabies following  test injection. 
S  =  mouse  survived  40 days.  --  --  dilution  not  tested. 
2  vaccine failed to immunize, whether given subcutaneously or intraperi- 
toneally.  The  No.  1  vaccine  likewise  failed  to  immunize  when  given 
subcutaneously,  whereas  intraperitoneally  in  0.6  cc.  or  0.1  cc.  doses  it 
immunized against  four and  two  lethal  doses  respectively.  The  dose  of 
0.6 cc. represents 5 times the dose for 10 kilo dogs per gram of body weight, 
while 0.1  cc. corresponds to the canine dose. 
0.6  cc.  of  chloroformized  vaccine  given  intraperitoneally  appeared  to 
irritate the peritoneum.  The mice seemed to be in pain for about an hour, 
were  hyperirritable,  and  occasionally  developed  transitory  convulsions. 
The discomfort, although causing loss of appetite for a  day or so, seemed 
relatively  harmless. 
Experiment 5.--Batches of thirty Swiss mice 3 to 4 weeks of age were given a single 
intrapcritoneal injection of vaccine diluted 1 to 10 in the following manner.  Batch A 102  IMMUNIZING  POTENCY  OF  ANTIRABIES  VACCINES 
received 0.6 cc. of No. 3 chloroformized vaccine and batch B 0.1 cc. of the same prepa- 
ration; batch  C 0.6 cc. of No. 3 phenolized vaccine, and batch D  0.1  cc. of the same 
sample; batch E  received 0.6 cc. of No. 2 chloroformized vaccine, batch F  0.1  cc., and 
batch G 0.6 cc. of No. 7 phenolized vaccine.  Batch H  remained unvaccinated as con- 
TABLE  XII 
Immunizing Effects of Canine Antirabies  Vaccine on Mice 
Comparison of Chloroformized and Phenolized Vaccines 
Mouse group 
t. No. 3 ehloro- 
formized 0.6 cc. 
~. No. 3 chloro- 
formized 0.1 cc. 
2. No. 3 phenol- 
ized0.6ec. 
D. No. 3 phenol- 
ized 0.1 cc. 
E. No. 2 ehloro- 
formized 0.6 oc. 
F.  No. 2 chloro- 
formlzed 0.1 cc. 
3. No. 7 phenol= 
ized 0.6 cc. 
If.  No vaccine 
~. No.  3  chloro- 
formized 0.6  cc. 
B. No.  3 chloro- 
formized 0.1 cc. 
~,. No. 3 phenol- 
ized 0.6 cc. 
D. No. 3 phenol- 
ized 0.1 cc. 
E. No. 2 chloro- 
formized 0.6cc. 
F. No.  2  chloro- 
formized 0.1  cc, 
~J.  No.  7  phenol- 
ized 0.6 cc. 
[-I. No vaccine 
Test 
virus 
Fate of mice inoculated intramuscularly with 0.01 cc. virus 
in dilutions 
J 
1:20  1:40  1:80  1:160  1:320 
15811  *20,  S,S,S  S,S,S,S  S,S,S,S 
9,15, 20, S  20, S,S,S  ~14,  S,S,S 
8,10,11,11  12,15, S,S  15,18. S,S 
9,18, 20, 20  17,18,18, S [ 12, 26, S, S 
10,11,12,20  15,17,18, S  15, S,S,S 
12,15,19, S  10,12,15, S  10,17,18,27 
10,16, 20, 20  13,18,18, S  14, 23, S, S 
10,  10,  12  9,11,13,18  11,17,28 
--  9,  17,  S,S  S,S,S,S 
--  12,  16,  S  S,  S,  S,  S 
--  9,  17,  S  9, 9, 9,  S 
--  7, 9  9, 9,  S 
7,9,15  9,  S,S 
--  7, 9,10  9,10,13 
--  9,10,15  10,10, S 
--  --  9,9,10,11 
Sk. 
1:.o  1:1,2 o 
9,  S, fi  S,S,S,  S 
* Day of death from rabies following test injection. 
S =  mouse survived 40 days.  -- =  dilution not tested. 
trols.  At  the  same  time,  0.03  cc.  of  each  vaccine  diluted  i  to 10 was  injected 
intracerebraUy into five mice. 
3 weeks later the vaccinated and control mice were divided into two equal lots for 
testing against two strains of rabies virus, one recently isolated from a  rabid dog and 
passed through seven mice, the other isolated from a skunk and passed through 156 mice. LESLIE  T.  WEBSTER  103 
0.01 cc. of virus in dilutions from 1:20 to 1:1,280 was injected into the gastrocnemius 
muscle. 
The results of this experiment are  shown in  Table  XII.  All vaccines 
proved non-virulent.  The  early passage  15811 test  virus was  somewhat 
irregular in its effects but was fatal to at least two of four mice through the 
1:320 dilution.  0.01  cc. of 1:320 is taken, therefore, as 1 lethal dose, al- 
though it is possible that the titre may have been somewhat higher.  None 
of the vaccines gave more than 2 M.L.D. protection except the No. 3 chloro- 
formized preparation.  This  vaccine,  in  the  0.6  cc.  dose,  which  is  ap- 
proximately 5 times that for dogs per gram of body weight, protected the 
vaccinated mice against sixteen lethal muscle doses.  0.1 cc., the dose cor- 
responding  to  that  for  dogs,  actually  seemed  to  give  some  immunity, 
although if one considers the fatalities in high dilutions as retroactive, the 
irregularities  bring  the  immunity below  the  level  of  significance.  The 
results following injection of similar batches with the  156 mouse passage 
Sk. strain were more regular and  similar  to  those  with the  15811 strain. 
The virus in non-vaccinated mice was fatal regularly through the  1:320 
dilution and to two of four in the 1 : 640 dilution.  This is taken, therefore, 
as the end point.  No vaccine except the No. 2 chloroformized preparation 
immunized the mice against more than 2 M.L.D. of test virus.  This latter 
vaccine, however,  again immunized not only against eight muscle doses, 
when given in a 0.6 cc. dose, but equally as well in a 0.1 cc. dose. 
The chloroformized vaccines given intraperitoneally again proved irrita- 
tive in contrast to the phenolized preparations which caused no reaction. 
Experiment 6.--Batches of fifteen mice, 3 to 4 weeks old, were given a single intra- 
peritoneal injection of vaccine  diluted 1 to 10 in the following  manner. BatchA received 
0.6 cc. of No. 1, 20 per cent chloroformized  vaccine and batch B 0.1 cc. of the same 
preparation.  Batch  C received 0.6 cc. of No. 1,33½ per cent chloroformized  vaccine, 
and batch D 0.1 cc. of the same.  Batch Ewas given 0.6 cc. of No. 5 phenolized  vaccine, 
batch F 0.6 cc. of No. 6 vaccine, and batch G 0.6 cc. of No. 8.  Batch H was left un- 
vaccinated as controls.  At the same time, 0.03 cc. of each vaccine diluted 1 to 10 was 
injected intracerebrally into five mice. 
3 weeks later the unvaccinated  and vaccinated  mice  were  given the early passage 15811 
strain of rabies virus, precisely as described in Experiment 5. 
The results of this test are given in Table XIII.  The vaccines proved 
non-virulent.  Again, the early passage strain proved somewhat irregular 
in its effects but killed 50 per cent or more mice through the 1 : 1,280 dilution 
which  was  regarded  as  the  end  point.  The  phenolized  vaccines  again 
proved generally non-effective but the No.  1 chloroformized preparation, 
whether in 20 per cent or 33] per cent concentration, immunized the mice 104  IMMUNIZING  POTENCY  0F  ANTIRABIES  VACCINES 
against at least eight intramuscular lethal doses.  0.1 cc. of the 20 per cent 
vaccine likewise immunized against four lethal doses. 
Taken together, the experiments show that no vaccines given subcutane- 
ously,  and no  phenolized vaccines  given  either  subcutaneously  or  intra- 
peritoneally  immunized mice  against more  than two intramuscular lethal 
doses  of  test  virus.  Chloroformized  vaccines  from  two  manufacturers, 
however,  immunized against  four to  sixteen  doses  when given  intraperi- 
toneally in amounts 5 to 10 times that advocated for dogs per gram of body 
TABLE  XIII 
Immunizing  Effects of Canine Antirabies  Vaccines 
Further Comparison of C  klor  of  or  mized and P kenolized Vaccines 
Mouse group 
A.  No. 1 chloroformized 20% 
0.6 cc. 
B.  No. 1 chloroformlzcd 20% 
0.1 cc. 
C.  No. 1 chloroformizcd 33½% 
0.6 ec. 
D. No. 1 chloroformized 33|% 
0.1 cc. 
E. No. 5 phenolized 33]t% 
0.6 cc. 
F. No. 6  phenolized  331% 
0.6 cc. 
G. No. 8 phenolized 33t% 
0.6 cc. 
H. No vaccine 
Fate of mice inoculated intramuscularly with virus in dilutions 
1:80 
17, S, S, S 
12, 12, 13, 15 
16, 20, S, S 
12, 13, 14, S 
12, 13, 17 
1:160  1:320 
15, S,S,S  18, S,S,S 
12, 13, 15, 1(  17, S, S, $ 
14, S,S,S  12, S,S,S 
17, 19, S,S  16,17,22,  S 
13, 14, 15,  17 14,  29, S, 
[:40 
"13, 14, 23 
12, 12, 13 
21, S 
11, 15, 17 
13, 17, 25 
13, 16, S 
13, 17, S 
12, 12, 30, S 
12,22, S,S  12,12,20, 
12.16, S,S  12, 30, S, 
--  12, 12, 17 
~.S~ 
* Day of death from rabies following test injection. 
S  =  mouse survived 40 days.  --  =  dilution not tested. 
1:640 
S  S, S, S, S 
S  12, 19, S,S 
S  13, 17, 31, 2 
1:1,280  ~  ~5 
--  8 
--  4 
--  8 
--  <4 
--  2 
--  0 
--  0 
15,16,  S,  S  -- 
weight, and occasionally when given in amounts corresponding to the canine 
dose.  The chloroformized vaccines given intraperitoneaUy in 0.6 cc. doses 
caused  transitory  irritative  phenomena. 
DISCUSSION 
The mouse test described in this paper is believed to be reliable and at 
the same time to reproduce field conditions of exposure adequately.  Ac- 
cording  to  the  results  presented,  vaccination  with  10,000  intracerebral 
lethal  doses  of  virus,  although  potentially  dangerous,  nevertheless  im- 
munizes 3 weeks old mice against four or more intramuscular lethal doses LESLIE  T.  WEBSTER  105 
of test virus.  Most commercial phenolized vaccines fail to immunize but 
Kelser's chloroformized preparations generally give positive results.  The 
original virus-containing brain tissue probably contains about 3.3  ×  106 
mouse intracerebral lethal doses per cc. before inactivation and 1.1  X  106 
doses in the 33-~ per cent suspension.  Following inactivation with chloro- 
form, about 0.5 cc. of a  1 to 10 dilution, or 55,000 inactivated intracerebral 
mouse doses, is required to immunize a 3 weeks old mouse against four or 
more intramuscular test  doses.  These comparative figures must  be  re- 
garded,  of  course,  as  crude  comparative approximations not  as  definite 
values. 
The commercial vaccine of choice for further study is, according to the 
mouse test, the Kelser chloroformized vaccine; the dose for mice, 2  to 5 
times that now advocated for man or animals; the route, intraperitoneal 
instead of subcutaneous.  This preparation requires 60 to 90 days for com- 
plete  inactivation  and  under  the  above  conditions  is  irritating  to  the 
peritoneal cavity. 
These findings in mice require rigid  checking in other animal species. 
Such experiments are now in progress in dogs. 
CONCLUSIONS 
I.  A  quantitative practical  mouse test  is  described for measuring the 
immunizing potency of  antirabies  vaccines. 
2.  Virulent  virus,  injected  intraperitoneally  as  a  vaccine,  immunized 
mice within i0 days and for a period of at least 9 months.  Demonstrable 
neutralizing  antibodies  accompanied  this  immunity.  Virus  given  sub- 
cutaneously failed to immunize as effectively.  The margin between im- 
munizing and infecting dose of vaccine was small. 
3.  Commercial vaccines containing virulent virus prepared for the treat- 
ment of man gave results similar to those obtained with laboratory virus. 
4.  Commercial vaccines inactivated with phenol and prepared for the 
treatment of man in general failed to  immunize mice.  None  contained 
virulent  virus.  The  phenolized preparation  from  one  commercial firm, 
however, as also the chloroformized preparation from another, immunized 
mice consistently when given intraperitoneally in quantities approximating 
5  times that advocated per gm. of body weight in man. 
5.  Commercial  canine  vaccines  inactivated  with  phenol  proved  non- 
virulent  and  failed  to  immunize mice. 
6.  Commercial  canine  vaccines  inactivated  with  chloroform  (Kelser) 
proved non-virulent but  capable  of  immunizing mice  provided a  single 106  IMMUNIZING  POTENCY  OF ANTIRABIES  VACCINES 
intraperitoneal injection of 2 to 5 times that prescribed for dogs per gin. of 
body weight was given. 
7.  Chloroformized vaccines proved irritative to the peritoneum of mice. 
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